C57BL/6J and DBA/2J strains present opposite sex differences in flash visual evoked potential latency: A possible confusing factor in gender studies on neurological diseases’ transgenic models

Loizzo, Stefano; Rimondini, Roberto; Campana, Gabriele; Fortuna, Andrea; Maroccia, Zaira; Martorana, Alessandro; Koch, Giacomo

doi:10.1016/j.brainresbull.2021.08.005

Brain Research Bulletin

2021

DOI: 10.1016/j.brainresbull.2021.08.005

|View full text |Cite

C57BL/6J and DBA/2J strains present opposite sex differences in flash visual evoked potential latency: A possible confusing factor in gender studies on neurological diseases’ transgenic models

Stefano Loizzo

Roberto Rimondini

Gabriele Campana

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Assessment of Innovative Pharmacological Targets in Schizophrenia

Reynolds de Sousa,

Ribeiro,

Novais

2024

Curr Treat Options Psych

View full text Add to dashboard Cite

Purpose of review Schizophrenia is a disorder with an approximate prevalence of 1% associated with great impairments in daily life functioning and important distress. The pharmacological treatments available thus far address, almost exclusively, the positive symptoms of the disorder, leaving cognitive and negative symptoms without an effective treatment. Additionally, a significant group of patients presents treatment-resistant forms of the disorder, and the schizophrenia drug pipeline has been stagnant. This review examines the existing evidence on potential novel drug targets for the disorder. Recent findings Several systems have been implicated in the pathophysiology of schizophrenia and several agents addressing disturbances in those systems have been tested in recent years. Summary We summarize significant findings on the multiple systems disrupted in schizophrenia (e.g. neurotransmitters, hormones, inflammation-related, intracellular mechanisms) and discuss potential strategies to target those disturbances. We review some new drugs developed for and tested in the patients/models of the disorder.

show abstract

Assessment of Innovative Pharmacological Targets in Schizophrenia

Reynolds de Sousa,

Ribeiro,

Novais

2024

Curr Treat Options Psych

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

C57BL/6J and DBA/2J strains present opposite sex differences in flash visual evoked potential latency: A possible confusing factor in gender studies on neurological diseases’ transgenic models

Cited by 1 publication

References 51 publications

Assessment of Innovative Pharmacological Targets in Schizophrenia

Assessment of Innovative Pharmacological Targets in Schizophrenia

Contact Info

Product

Resources

About